APHAmphenol Corporation
Industry AI semis Updated 24 Sep 2026
The idea
~20x FY28 model EPS for the connector and cable supplier inside every AI rack; the bull case is AI content per rack compounding, 22% growth holding and a 21.5% margin.
Events to watch
- Quarterly IT Datacom growth
- the FY2026 10-K re-test of whether acquisitions are 'immaterial in the aggregate' (the SEC asked)
- buyback nearly exhausted ($411m left)
How we got the target
Scorecard: base ~$98 (~20x FY28E model EPS). Time frame: FY2028.
Target: from the research notes. Prices: market data get_latest_stock_price, close of 2026-09-22 (fetched 2026-09-23)
What would prove it wrong
6 warning signsBook-to-bill falls below 1.0.
Details
It was 1.23 on a record $10.7bn of orders in Q2 2026, with orders +63% organically. This is disclosed on the call every quarter and leads revenue by roughly two quarters; it is the earliest number that would say the interconnect build has turned.
Organic IT datacom growth breaks down.
Details
43% of Q2 2026 sales, +63% organic, and management says virtually all of that growth is AI. Below ~20% organic and the mix that justifies the multiple is gone; the communications networks line (−6% organic, guided down mid-teens sequentially) is what that looks like when it happens.
Gross margin retreats toward the historical band.
Details
40.5% in Q2 2026 against ~32% for 2021–2023. Two consecutive quarters below 36% would say the pricing of AI interconnect is normalising, not that volumes fell.
A goodwill impairment, or a CommScope contribution below the raised $4.6bn / $0.30.
Details
Goodwill $17.6bn against equity $15.5bn leaves no cushion; management raised the CommScope number once already, so a cut would be a reversal of its own guide.
The next 10-K discloses a customer at or above 10% of net sales.
Details
Nothing has been tagged since an 11% largest customer for FY2020. At 43% of sales in one AI-driven end market, a re-appearance of that disclosure would change the risk from "unknown concentration" to a measured one.
The conservative-guider pattern breaks (added 2026-09-24, S8).
Details
Ten of ten guides beaten above the top of the range from Q3 2024 to Q2 2026. The first quarter that lands inside or below its own range (sales or adjusted EPS), or a second quarter of further discrete tax add-backs after the Q3 2026 release, says the cushion — already narrowed from +23-24% to +7-16% on EPS — is gone.
How far along
7 of 10 steps done · 3 done in a group review
Next step
re-test "immaterial in the aggregate" at the FY2026 10-K. The SEC's Office of Manufacturing put exactly that question to Amphenol about its 2024 and 2025 acquisitions, the company answered that they were not material individually or together, and the staff closed the review on 2025-06-25 without requiring anything. Seven months later Amphenol closed CommScope for ~$10.5bn — by its own words "the largest acquisition in the Company's history" — which added ~$7.0bn of goodwill in one quarter and took goodwill above book equity. The answer that satisfied the staff was about a different roll-up than the one that now exists.
Needs your decision
S6 product test / expert call, S7 conviction. open Open (pipeline): S8 rows pending — the Q3 2026 guide ($9.3-9.4bn / $1.40-1.42 pre-split, late October 2026) and the raised CommScope FY2026 contribution ($4.6bn / $0.30, FY2026 10-K); S2's CommScope return (FY2027 10-K).
Failed checks
none. S0/S4/S7 are not closed by design (cluster stages, carried forward). S3's gate-minimum transcript gap is closed (both 2026 calls read in full, dossier-2026-09-24.md). ⚠️ Thread from the dodge log: the size and economics of the AI mix by technology (copper / optics / CPO) was dodged in Q1 and Q2 2026 — see the S9 trigger below. ⚠️ EQ: $429m of discrete tax charges excluded from adjusted EPS in three straight quarters.
Who runs it
The Front OfficeStep by step
- S0How it does as AI gets cheapDone in a group review
carry-forward (cluster: AI-capex complex — cluster pass, 2026-09-20)
cluster verdict is.
⚠️ SPLIT; APH sits on the "seller of the shortage" side that passes, and is one of the few that sells into the build without financing any of it. Owner checks dropped 2026-09-21 (README §Stage 0 override).
- S1Where the idea came fromDone
watchlist (owner, Apple Stocks, 2026-09-20); no Tier 0 promotion.
- S2Quick deal-breaker checkDone
FY25 rev $23,094.7m +52%, GM 36.9%, op margin 25.4%, OCF $5,374.7m, capex $996.6m, FCF $4,378.1m. Net debt $13,392.2m = 1.46x LTM EBITDA. Share count ~+2% over four years once both 2:1 splits are undone. Survives comfortably.
⚠️ goodwill $17,554.7m now exceeds book equity $15,491.6m, and FY25/Q2-26 margins are cycle-peak against a decade at ~32% GM. Capital allocation (2026-09-24): COMPOUNDS — FY21-25 OCF $14.4bn went 66% to acquisitions, 23% buybacks, 19% capex, 19% dividends (debt-funded gap); ROIC 17-21% FY20-24, 29% FY25; incremental ROIC ~32% (NOPAT $1.30bn→$4.51bn over IC $7.58bn→$17.57bn, FY20→FY25); zero goodwill impairments 2019-25; buybacks ~offset option dilution (count +2% in four years), bought at ~$43-70 post-split vs $82.19. CommScope's $10.5bn return untested (IC $29.0bn at 2026-06-30, ~20% LTM).
- S3Reading the company's reportsDone
(gate-minimum)
FY25 10-K risk factors + MD&A + Note 15, Q2 2026 10-Q MD&A and debt notes, DEF 14A ownership and incentive criteria, one transcript (Q2 2026, turns 3-20 of 48), and the full SEC comment-letter exchange on the FY2024 10-K. Three disclosed risks named with locators.
Full notes
One transcript not two; no efts.sec.gov auditor/restatement sweep. Form 4 amounts not itemised. Both 2026 calls now read in full (2026-09-24). EQ: 2 flags — discrete tax charges added back three quarters running ($429m, Q4-25 to Q2-26, against a $100m first "best estimate"), acquisition costs added back 3 of 3 years (small; adjusted EPS was at or below GAAP through FY25 because excess tax benefits are stripped out). Clean on cash: SBC 0.6% of revenue / 3.1% of FCF (FY25), OCF/NI 1.30 / 1.15 / 1.25 (FY23-25), accruals negative, DSO 67-72 and DIO 90→79 days. Watch H1-26 working-capital build of $1,176m.
- S4Rivals and suppliersDone in a group review
carry-forward (cluster: AI-capex complex — cluster pass, 2026-09-20)
- S5Who owns the stockDone
proxy 5% table (2026-03-23), 13F Q2-26 by manager, 13D/G census (all passive, no 13D), Form 4 and Form 144 cadence, FINRA short interest, buyback authority and the live S-3ASR shelf.
⚠️ the Q2-26 13F quarter is incompletely ingested (1,614 filers vs 2,099) — FMR, JPMorgan, Geode, Morgan Stanley and others have no filing in it yet, so no "exit" may be read from their absence.
- S6What workers and customers sayDone
carry-forward (cluster: AI-capex complex — cluster pass 2: S6 for 41 names, S0/S4/S7 for three, 2026-09-21)
closed there for all 41 members, and APH is named as one of the four thin ones (Evercore opinion plus a Glassdoor reading, no independent operational evidence). Product test / expert call open OPEN (user)
- S7The case for it, and pricesDone in a group review
carry-forward (cluster: AI-capex complex — cluster pass, 2026-09-20)
conviction open OPEN (user) · valuation (bear/base/bull; moved from S8 2026-09-23): ~30x FY26E and ~20x FY28E model EPS at $80.86 (2026-09-21), post-split. Base case ~$98, bear ~$42, bull ~$147.
- S8Do the bosses keep their word?Done
17 rows: 12 beat, 3 met, 2 missed, 0 withdrawn
CONSERVATIVE. All ten quarterly/full-year sales and adj-EPS guides (Q3-24 → Q2-26) beaten above the top of the range on the only guide; both big closings (Andrew, CommScope) earlier than first guided.
Full notes
Misses: Lütze Europe closed days late; a $100m China-tax "best estimate" became $230m, plus $199m more tax charges, in three quarters. Current team made all 17 (Norwitt CEO, Chairman since May 2026. Lampo CFO) — no departures. Beat cushion narrowing: EPS +23-24% (Q1-Q2 25) → +7-16% (Q4-25 to Q2-26). Dodges: 5 in two calls. AI/optics mix sizing dodged in Q1 and Q2 2026 (not a guided topic).
- S9What to watch nextDone
trigger written. Tier 0 EDGAR sweep covers the feed (cik 820313)
Sources and notes
Sources 13 documents
- Full notes, 24 Sep 2026
- Full notes, 21 Sep 2026
- AI-capex complex — cluster pass, 2026-09-20
- AI-capex complex — cluster pass 2: S6 for 41 names, S0/S4/S7 for three, 2026-09-21
- EDGAR filings CIK 820313
| Short name | Document | Where it came from | Read on |
|---|---|---|---|
| 10K-FY25 | Amphenol 10-K for FY ended 2025-12-31, filed 2026-02-11 | https://www.sec.gov/Archives/edgar/data/820313/000110465926013549/aph-20251231x10k.htm | 2026-09-21 |
| 10Q-Q2-26 | Amphenol 10-Q for the quarter ended 2026-06-30, filed 2026-07-31 | https://www.sec.gov/Archives/edgar/data/820313/000110465926089194/aph-20260630x10q.htm | 2026-09-21 |
| DEF14A-26 | Amphenol DEF 14A filed 2026-04-08 (ownership tables as of 2026-03-23) | https://www.sec.gov/Archives/edgar/data/820313/000110465926040688/tm261344-1_def14a.htm | 2026-09-21 |
| CORRESP-2025-06-20 | Amphenol response letter to SEC Division of Corporation Finance, Office of Manufacturing, filed 2025-06-20 (supplemental to the 2025-05-16 response on the FY2024 10-K) | https://www.sec.gov/Archives/edgar/data/820313/000110465925060794/filename1.htm | 2026-09-21 |
| UPLOAD-2025-06-25 | SEC staff letter closing the review of Amphenol's FY2024 Form 10-K, filed 2025-06-25 | https://www.sec.gov/Archives/edgar/data/820313/000000000025006621/filename1.pdf | 2026-09-21 |
| 8K-2026-08-06 | Amphenol 8-K Item 8.01, filed 2026-08-06 — board approval of a two-for-one stock split | https://www.sec.gov/Archives/edgar/data/820313/000110465926091969/tm2622441d1_8k.htm | 2026-09-21 |
| 8K-2026-09-04 | Amphenol 8-K Item 8.01, filed 2026-09-04 — the two-for-one split effected 2026-09-02 | https://www.sec.gov/Archives/edgar/data/820313/000110465926105485/tm2624775d1_8k.htm | 2026-09-21 |
| CALL-Q2-26 | Amphenol Q2 2026 earnings call, 2026-07-29 (speaker-labelled transcript) | Equibles GetEarningsCallTranscript APH FY2026 Q2 — https://equibles.com/stocks/aph/earnings-calls | 2026-09-21 |
| 13F-Q2-26 | Institutional holders by manager, 13F report date 2026-06-30 (ingestion incomplete — see note) | python ledger/research/tools/threespread.py holders APH | 2026-09-21 |
| EDGAR-INDEX | Amphenol EDGAR filing index (CIK 820313) | https://data.sec.gov/submissions/CIK0000820313.json | 2026-09-21 |
| RELEASE-Q2-26 | Amphenol second-quarter 2026 earnings release, 8-K Item 2.02 Ex. 99.1, filed 2026-07-29 | https://www.sec.gov/Archives/edgar/data/820313/000110465926087904/aph-20260729xex99d1.htm | 2026-09-24 |
| 8K-2026-02-05 | Amphenol 8-K Items 5.02/7.01, filed 2026-02-05 — board succession plan (Ex. 99.1) | https://www.sec.gov/Archives/edgar/data/820313/000110465926010676/tm265098d1_ex99-1.htm | 2026-09-24 |
| 8K-2025-05-14 | Amphenol 8-K Item 5.02, filed 2025-05-14 — principal accounting officer designation | https://www.sec.gov/Archives/edgar/data/820313/000110465925048479/tm2515117d1_8k.htm | 2026-09-24 |
Links to other companies 29 links
| From | Link | To | Date | Where it says so |
|---|---|---|---|---|
| Adam Norwitt | officer of | APH | 2026-07-29 | CALL-Q2-26 — opening remarks, first executive turn |
| Craig A. Lampo | officer of | APH | 2025-06-20 | CORRESP-2025-06-20 — signature block |
| APH | acquired | CommScope | 2026-01-09 | 10K-FY25 — Note 15, Subsequent Events |
| APH | context | CommScope | 2026-07-29 | CALL-Q2-26 — CEO opening remarks |
| APH | acquired | Andrew (acquired from CommScope, 2025) | 2025-12-31 | 10K-FY25 — Item 1A, risk factor on integrating newly acquired businesses |
| APH | acquired | Trexon | 2025-12-31 | 10K-FY25 — Item 7, Liquidity and Capital Resources |
| APH | acquired | Elcom (Lainate, Italy) | 2026-07-29 | CALL-Q2-26 — CEO opening remarks |
| Wilder Technologies | supplier dependency | APH | 2026-07-29 | CALL-Q2-26 — CEO opening remarks |
| IT datacom / AI data-centre end market (Amphenol's own end-market label) | customer of | APH | 2026-06-30 | CALL-Q2-26 — CEO opening remarks, IT datacom paragraph |
| APH | channel concentration | IT datacom / AI data-centre end market (Amphenol's own end-market label) | 2025-12-31 | 10K-FY25 — Item 1 and Item 1A — no customer named at or above 10% of net sales |
| TE Connectivity | competitor | APH | 2025-12-31 | 10K-FY25 — Item 1, Competition |
| Molex | competitor | APH | 2025-12-31 | 10K-FY25 — Item 1, Competition |
| ICT Luxshare | competitor | APH | 2025-12-31 | 10K-FY25 — Item 1, Competition |
| Foxconn Interconnect Technology | competitor | APH | 2025-12-31 | 10K-FY25 — Item 1, Competition |
| Corning | partner and competitor | APH | 2026-01-09 | 10K-FY25 — Item 1, Competition; Note 15, Subsequent Events |
| Aptiv | competitor | APH | 2025-12-31 | 10K-FY25 — Item 1, Competition |
| SEC Division of Corporation Finance, Office of Manufacturing | regulator of | APH | 2025-06-25 | CORRESP-2025-06-20 — opening paragraph |
| SEC Division of Corporation Finance, Office of Manufacturing | event | APH | 2025-06-25 | UPLOAD-2025-06-25 — body of the staff letter |
| The Vanguard Group | holds | APH | 2026-03-23 | DEF14A-26 — Security Ownership of Certain Beneficial Owners, footnote (2) |
| BlackRock, Inc. | holds | APH | 2026-06-30 | 13F-Q2-26 — row 1, BlackRock, Inc.; https://www.sec.gov/Archives/edgar/data/2012383/000201238326003238/ |
| FMR LLC | holds | APH | 2026-03-23 | DEF14A-26 — Security Ownership of Certain Beneficial Owners, footnote (4) |
| State Street Corp | holds | APH | 2026-06-30 | 13F-Q2-26 — row 2, STATE STREET CORP; https://www.sec.gov/Archives/edgar/data/93751/000009375126000507/ |
| T. Rowe Price Associates, Inc. | holds | APH | 2026-06-30 | 13F-Q2-26 — row 3, PRICE T ROWE ASSOCIATES INC /MD/; https://www.sec.gov/Archives/edgar/data/80255/000008025526000519/ |
| APH | event | APH | 2026-09-02 | 8K-2026-09-04 — Item 8.01, Other Events |
| APH | governance structure | APH | 2026-04-08 | DEF14A-26 — Compensation Discussion & Analysis, quantitative performance criteria |
| Adam Norwitt | officer of | APH | 2026-07-29 | RELEASE-Q2-26 — opening quotation, first paragraph |
| Adam Norwitt | director of | APH | 2026-02-04 | 8K-2026-02-05 — Ex. 99.1, first paragraph |
| Craig A. Lampo | officer of | APH | 2026-07-31 | 10Q-Q2-26 — Signature page |
| Craig A. Lampo | officer of | APH | 2025-05-08 | 8K-2025-05-14 — Item 5.02 |
History 3 entries
- 2026-09-21 — first pass, slot
names-ai-capex-3, model-drafted unattended by the cloud research routine. S1, S2, S3 (gate-minimum), S5 and S9 closed; S0/S4/S7 carried forward from the 2026-09-20 cluster file and S6 from the 2026-09-21 one; S8 modelled and left open. Evidence and access limits in dossier-2026-09-21.md. Nothing here is human-verified. - 2026-09-23 — stage redefinition, owner decision (WATCHLIST_PLAN.md §25): S8 is now Management credibility and is not yet run for this name; the old S8 valuation figures moved to the
valuation:line under S7, and any proposed buy price or position size was removed (the pipeline no longer drafts either). No research was redone. S2 capital allocation and S3 earnings quality are also pending, in the same backfill slot. - 2026-09-24 — backfill, slot
backfill-2026-09-23-3, model-drafted by a manually started cloud session; nothing here is human-verified. Added S8 management credibility (17-row say-vs-do table, conservative, ✅), S2 capital allocation (compounds; S2 glyph unchanged) and S3 earnings quality (2 flags; S3 glyph unchanged), read the Q1 and Q2 2026 calls in full from the market data archive and started the dodge log. Added one kill criterion (the guide-beat pattern breaking) and an S9 trigger from the dodge thread; S7 valuation base case not haircut (S8 is not over-promises). Four officer edges added to relationships.yaml. Sources: EDGAR releases, 8-Ks, Q2-26 10-Q and XBRL; Equibles 0 calls. Evidence in dossier-2026-09-24.md.
Full notes, 24 Sep 2026 21 min read
APH — dossier, 2026-09-24 (backfill: S8, S2 capital allocation, S3 earnings quality)
Slot backfill-2026-09-23-3. Model-drafted by a manually started cloud session; nothing here is human-verified. This file holds only the three checks added on 2026-09-23 (WATCHLIST_PLAN.md §25) plus the transcript section for the calls read for them. Every other stage stands as written in dossier-2026-09-21.md. Anything from background knowledge is marked [background].
Share basis. Every per-share figure below comes from a filing or call dated before the 2026-09-02 two-for-one split and is pre-split unless it says otherwise; guide and result are on the same basis, so the say-vs-do scoring is unaffected. Post-split figures are labelled.
Price reference: $82.19 close, 2026-09-23 (market data get_latest_stock_price NYSE:APH, post-split).
Sources this pass. EDGAR only for filings (User-Agent ddboard-research <owner email>): the nine earnings releases (8-K Item 2.02, Ex. 99.1) filed 2024-07-24, 2024-10-23, 2025-01-22, 2025-04-23, 2025-07-23, 2025-10-22, 2026-01-28, 2026-04-29 and 2026-07-29; the acquisition announcements (8-K Item 7.01 Ex. 99.1, 2024-07-18 and 2025-08-04); the three Item 5.02 8-Ks in the window (2025-05-14, 2026-01-08, 2026-02-05); the Q2 2026 10-Q (cash-flow statement, repurchase note, signature); XBRL companyfacts for CIK 820313. Transcripts from the archive ledger/research/_transcripts/APH/ (market data, eight calls FY2024-Q3 to FY2026-Q2; call dates from _transcripts/index.json). Equibles: 0 calls (EDGAR answered every row). market data: 2 calls (price; get_profitability_ratios refused — the free plan covers two years, so ROIC below is computed from XBRL, not cross-checked).
Quote discipline: transcript quotes were checked by exact substring against the archived JSON bytes; filing quotes against a whitespace-collapsed text extraction of the EDGAR HTML (same convention as relationships.yaml). Turn numbers [n] are line positions in the market data content string.
S8 — management credibility
How Amphenol guides. One quarter ahead, sales and Adjusted Diluted EPS as a $100m / $0.02 range, in the earnings release's Outlook paragraph and read out on the call; a full-year range only at the Q3 call (it is then Q4 plus nine months of actuals). No mid-quarter revisions exist in the window, so first guide = only guide for every quarterly row. The written outlook excludes acquisitions not yet closed ("This guidance does not include the impact of acquisitions that have not yet closed", 2024-10-23 and 2025-10-22 releases), which flatters a beat in any quarter where a deal closed after the guide — noted on the one row where it matters (Q1 2025, Andrew).
Who promised. On the calls the outlook is read by the CEO: the market data speaker label at the outlook passage is "Adam Norwitt" (FY2024-Q3 [3], FY2024-Q4 [3], FY2025-Q1 [3], FY2025-Q3 [3]), "R. Norwitt" (FY2025-Q2 [3], FY2026-Q1 [3]) and "Richard Adam Norwitt" (FY2026-Q2 [3]). On FY2025-Q4 the passage sits inside turn [2], labelled "Craig Lampo"; the transcript has no second executive label before Operator at [3], i.e. the CFO's and CEO's prepared remarks are merged into one turn — the row is attributed to the release (company, written) with that label noted. market data gives names only; roles from EDGAR as of each date: R. Adam Norwitt, President and CEO through the window and Chairman and CEO since the May 2026 annual meeting (8-K 2026-02-05 Ex. 99.1: "has appointed R. Adam Norwitt, currently serving as President and Chief Executive Officer, to the additional role of Chairman of the Board"; Q2 2026 release: "said Amphenol Chairman and Chief Executive Officer, R. Adam Norwitt"); Craig A. Lampo, CFO through the window (8-K 2025-05-14 Item 5.02, which moved only the principal-accounting-officer designation to the controller, Mr. Lampo "who continues in his capacity as Chief Financial Officer and the Company’s principal financial officer"; Q2 2026 10-Q signature, 2026-07-31: "Executive Vice President and Chief Financial Officer").
Departed check. Three Item 5.02 8-Ks in the window, none a CEO or CFO departure: 2025-05-14 (principal accounting officer designation to Michael R. Ivas, VP and Corporate Controller); 2026-01-08 (Sanjiv Lamba joins the board); 2026-02-05 (Norwitt adds Chairman; Martin Loeffler retires from the board in May 2026). EDGAR filing index shows no 5.02 after 2026-02-05. Every row below was made by the team in charge today. No departed rows.
Say vs do (Q3 2024 → Q2 2026 results; eight quarters)
Actuals: net sales from XBRL RevenueFromContractWithCustomerExcludingAssessedTax (Q4 2024 from the 2025-01-22 release table; Q4 2025 derived as FY2025 less the three 10-Q quarters); Adjusted Diluted EPS from each release's headline bullets and reconciliation.
| # | Promise (period · metric · range) | Made where · by whom | Result · locator | vs top of range | Score |
|---|---|---|---|---|---|
| 1 | Q3 2024 · sales $3.70–3.80bn · adj EPS $0.43–0.45 | release 2024-07-24, Outlook · company (written); the Q2 2024 call is not in the archive | $4,038.8m · $0.50 — release 2024-10-23 bullets | +6.3% · +11% | beat |
| 2 | Q4 2024 · $3.95–4.05bn · $0.48–0.50 | call 2024-10-23 [3] · Adam Norwitt (CEO); release same day | $4,317.9m · $0.55 — release 2025-01-22 | +6.6% · +10% | beat |
| 3 | FY 2024 · $14.85–14.95bn · $1.82–1.84 | same call and release | $15,222.7m · $1.89 — release 2025-01-22 reconciliation | +1.8% · +3% | beat |
| 4 | Q1 2025 · $4.00–4.10bn · $0.49–0.51 | call 2025-01-22 [3] · Adam Norwitt (CEO) | $4,811.0m · $0.63 — release 2025-04-23. Andrew and LifeSync closed after the guide and were outside it; organic growth alone was 33% against a guided 23–26% total | +17.3% · +24% | beat |
| 5 | Q2 2025 · $4.90–5.00bn · $0.64–0.66 | call 2025-04-23 [3] · Adam Norwitt (CEO) | $5,650.3m · $0.81 — release 2025-07-23 | +13.0% · +23% | beat |
| 6 | Q3 2025 · $5.4–5.5bn · $0.77–0.79 | call 2025-07-23 [3] · R. Norwitt (CEO) | $6,194.4m · $0.93 — release 2025-10-22 | +12.6% · +18% | beat |
| 7 | Q4 2025 · $6.0–6.1bn · $0.89–0.91 | call 2025-10-22 [3] · Adam Norwitt (CEO) | $6,439.0m (derived) · $0.97 — release 2026-01-28 | +5.6% · +7% | beat |
| 8 | FY 2025 · $22.66–22.76bn · $3.26–3.28 | same call and release | $23,094.7m · $3.34 — release 2026-01-28 reconciliation | +1.5% · +2% | beat |
| 9 | Q1 2026 · $6.90–7.00bn (incl. ~$900m CommScope) · $0.91–0.93 | release 2026-01-28, Outlook; call 2026-01-28 [2], label "Craig Lampo" (merged turn, see above) · company (written) | $7,620.1m · $1.06 — release 2026-04-29 | +8.9% · +14% | beat |
| 10 | Q2 2026 · $8.1–8.2bn · $1.14–1.16 | call 2026-04-29 [3] · R. Norwitt (CEO) | $8,758.1m · $1.35 — release 2026-07-29; includes an $80m / $0.04 net IEEPA tariff recovery, so $1.31 without it — still a beat | +6.8% · +16% | beat |
| 11 | Andrew (CommScope OWN/DAS) close · "first half of 2025" → "first quarter of 2025" | 8-K 2024-07-18 Ex. 99.1: "the deal is expected to close in the first half of 2025"; revised in release 2024-10-23: "now expect that transaction to close in the first quarter of 2025" · company (written) | closed in Q1 2025 — release 2025-04-23: "the Company is excited to have closed the acquisitions of LifeSync as well as CommScope’s OWN and DAS businesses" | earlier than first guide | beat |
| 12 | Lütze Europe close · by end of Q3 2024 | release 2024-07-24: "we expect to close on Lutze Europe, which has annual sales of approximately $100 million, by the end of the third quarter of 2024" · company (written) | release 2024-10-23: "the Company is excited to have closed the previously announced acquisition of Lütze Europe in early October 2024" | days late | missed (small) |
| 13 | CommScope CCS close · "first half of 2026" → "by the end of the first quarter of 2026" | 8-K 2025-08-04 Ex. 99.1: "the transaction is expected to close in the first half of 2026"; release 2025-10-22: "The Company now expects the CCS acquisition to close by the end of the first quarter of 2026." · company (written) | closed 2026-01-09 — FY2025 10-K Note 15 (see relationships.yaml, acquired edge) | earlier than first guide | beat |
| 14 | Trexon close · by end of Q4 2025 | release 2025-10-22: "Amphenol continues to expect the Trexon acquisition to close by the end of the fourth quarter of 2025." · company (written) | release 2026-01-28: "including the previously announced closing of the Trexon acquisition in November" | on time | met |
| 15 | China tax matter · $100m "best estimate", range $100m–~$300m | release 2026-01-28, reconciliation note (iii): "The $100.0 million accrual represents the Company’s current best estimate of the costs that may be incurred to resolve this matter, however the range of potential costs is estimated to be $100.0 million to approximately $300.0 million." · company (written) | one quarter later, release 2026-04-29 note (iii): "the Company recently received tax payment notices totaling $230.0 million" — accrued in full, plus $160.0m from reassessing tax-rate assumptions on prior years not under the China inquiry; Q2 2026 added $39.0m of reserves "for potential settlement of various foreign tax matters" (release 2026-07-29 note (iii)). $429m of discrete tax charges in three quarters against a $100m best estimate | China alone inside the range; total 4.3x the estimate | missed |
| 16 | 2026 net interest ≈ $200m a quarter | call 2026-01-28 [2] (CFO section, label "Craig Lampo"): "we expect 2026 quarterly interest expense, net of interest income from cash on hand, to be approximately $200 million" · Craig A. Lampo (CFO) | XBRL Q1 / Q2 2026: InterestExpenseNonoperating $207.9m / $213.7m against OtherNonoperatingIncomeExpense $21.8m / $17.5m → ~$186m / ~$196m net, if other income is mostly interest (the tag is broader) | ≈ | met |
| 17 | Adjusted ETR 27% for the rest of 2026 | call 2026-04-29 [2] · Craig Lampo (CFO): "the company increased its effective tax rate to 27% in the first quarter and expect that rate to remain for the remainder of 2026" | Q2 2026 adjusted ETR 27.0% — release 2026-07-29 reconciliation | one quarter in | met |
Not scored (open): Q3 2026 guide $9.3–9.4bn / $1.40–1.42 (call 2026-07-29 [3], Richard Adam Norwitt: "For the third quarter, we now expect sales in the range of $9.3 billion to $9.4 billion and adjusted diluted EPS in the range of $1.40 to $1.42."), reports late October 2026. CommScope FY2026 contribution: $4.1bn sales / $0.15 accretion (release 2026-01-28, "As previously disclosed"), reaffirmed on the Q1 2026 call [18] by R. Norwitt ("And we continue to expect the company to deliver this year, as we said, roughly $4.1 billion in sales and $0.15 of accretion."), raised to $4.6bn / $0.30 in the 2026-07-29 release — a raise, scored only when FY2026 is reported. Andrew accretion $0.06 → $0.09 (release 2025-04-23) is a raise with no separately reported result. Capex "at the high end of" 3–4% of sales "maybe slightly over that" in H2 2026 (call 2026-07-29 [28], Craig A. Lampo) — soft, checkable at the Q3/Q4 10-Q.
Tally: 17 rows — 12 beat, 3 met, 2 missed, 0 withdrawn. All 17 by the current CEO and CFO or in releases issued under them.
Dodge-log roll-up (§3.1, calls FY2026-Q1 and FY2026-Q2, detail below). Five dodges in two calls. One topic dodged in two consecutive quarters: the size and economics of the AI / optics mix — CPO revenue and profit implications (Q1, Delaney), content value vs copper volume (Q1, Giordano), the fibre share of the AI run rate (Q2, Daryanani). It is not a topic management itself guided — Amphenol has never given a technology split — so the strongest form of the signal (a dodge on one's own guide) is absent. Policy refusals on anything beyond one quarter (2027, Q1) are consistent with how the company guides and are logged as notes.
Verdict — conservative. Ten of ten quarterly and full-year sales/EPS guides beaten at the top of the range, all on the first (and only) guide, and both large-deal closings delivered earlier than first guided. The two misses are informative rather than damning: a small-deal closing a few days late, and a tax estimate — not a guide — that was exceeded 4.3x within two quarters, with the excess recurring into a third quarter and excluded from adjusted EPS each time (this is also the S3 earnings-quality flag). One trend to carry: the size of the EPS beat against the top of the range has narrowed from +23–24% (Q1–Q2 2025) to +7–16% (Q4 2025 – Q2 2026), and the sales beat to +5.6–8.9%. A conservative guider's cushion shrinking is what a slowing second derivative looks like before any number misses.
S2 — capital allocation
All figures $m, calendar fiscal years, from XBRL companyfacts (CIK 820313): OCF NetCashProvidedByUsedInOperatingActivities, capex PaymentsToAcquirePropertyPlantAndEquipment, acquisitions PaymentsToAcquireBusinessesNetOfCashAcquired, buybacks PaymentsForRepurchaseOfCommonStock, dividends PaymentsOfDividendsCommonStock, new debt ProceedsFromIssuanceOfSeniorLongTermDebt, repaid RepaymentsOfLongTermDebtAndCapitalSecurities, CP ProceedsFromRepaymentsOfCommercialPaper, SBC ShareBasedCompensation, option proceeds ProceedsFromStockOptionsExercised. H1 2026 from the Q2 2026 10-Q cash-flow statement.
| FY | OCF | Capex | Acquisitions | Buybacks | Dividends | Debt issued | Debt repaid | CP net | SBC | Option-exercise proceeds |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 1,540.1 | 360.4 | 2,225.4 | 661.7 | 346.7 | 752.1 | 912.6 | +796.3 | 83.0 | 288.5 |
| 2022 | 2,174.6 | 383.8 | 288.2 | 730.5 | 477.4 | 5.8 | 10.3 | −159.3 | 89.5 | 185.3 |
| 2023 | 2,528.7 | 372.8 | 970.4 | 585.1 | 500.6 | 354.9 | 15.7 | −632.6 | 99.0 | 394.5 |
| 2024 | 2,814.7 | 665.4 | 2,156.4 | 689.3 | 595.1 | 2,991.3 | 364.4 | 0 | 109.5 | 447.4 |
| 2025 | 5,374.7 | 996.6 | 3,818.6 | 665.2 | 802.2 | 8,921.7 | 401.7 | 0 | 135.4 | 553.0 |
| 5-yr | 14,432.8 | 2,779.0 | 9,459.0 | 3,331.8 | 2,722.0 | 13,025.8 | 1,704.7 | +4.4 | 516.4 | 1,868.7 |
| H1 2026 | 2,678.7 | 647.1 | 10,684.0 | 386.0 | 614.0 | 4,927.2 | 1,535.7 | — | 79.6 | 200.6 |
Where the five years of OCF went: acquisitions 66%, buybacks 23%, capex 19%, dividends 19% — 127% of OCF, the gap funded with debt (net issuance ~$11.3bn over the five years, most of it in late 2025 to pre-fund CommScope, which then took $10.7bn of H1 2026 cash). This is an acquirer that pays a dividend, not a buyback story.
SBC vs buybacks. SBC expense is small — $135.4m in FY2025, 0.6% of revenue — but it understates the dilution because Amphenol pays in options: exercise proceeds of $1,868.7m over five years against $3,331.8m of buybacks, so net cash spent retiring shares was ~$1.46bn. The buybacks do slightly more than offset the grants: diluted weighted shares went from 625.5m (FY2021) to 1,277.5m (FY2025) as filed, i.e. ~1,251m → ~1,278m after undoing the 2022 split, +2% over four years (XBRL WeightedAverageNumberOfDilutedSharesOutstanding; the same finding as S2 on 2026-09-21). Neutral: the programme holds the count roughly flat, it does not shrink it.
Returns. NOPAT = operating income × (1 − GAAP effective tax rate, tax expense over pre-tax income); invested capital = equity + long-term debt and finance leases (current and non-current) + non-controlling interest − cash − short-term investments, year-end, from XBRL.
| FY | Op income | Tax rate | NOPAT | Invested capital (year-end) | ROIC on average IC |
|---|---|---|---|---|---|
| 2020 | 1,638.4 | 20.5% | 1,302.2 | 7,580.3 | 17.5% |
| 2021 | 2,105.1 | 20.6% | 1,672.2 | 9,918.6 | 19.1% |
| 2022 | 2,585.8 | 22.3% | 2,008.8 | 10,217.0 | 20.0% |
| 2023 | 2,559.6 | 20.7% | 2,028.6 | 11,072.9 | 19.1% |
| 2024 | 3,156.9 | 18.9% | 2,559.1 | 13,398.1 | 20.9% |
| 2025 | 5,868.6 | 23.1% | 4,511.2 | 17,568.2 | 29.1% |
Incremental return, FY2020 → FY2025: ΔNOPAT $3,209.0m (1,302.2 → 4,511.2) over Δinvested capital $9,987.9m (7,580.3 → 17,568.2) = ~32%. Every year earned ~17–21% before the AI cycle took it to 29%. The CommScope test has not been sat yet: invested capital jumped to $29,005.3m at 2026-06-30 (equity 15,491.6 + debt 17,177.0 + 1,634.3 + NCI 121.5 − cash 4,729.4 − ST investments 689.7). On LTM operating income of $7,841.4m (dossier-2026-09-21 §S2) at the 27% adjusted tax rate management now uses, that is ~$5.7bn of NOPAT, ~20% on period-end capital — diluted from 25.7% at end-2025, still well above any plausible cost of capital. What CommScope earns on its $10.5bn is a FY2027 question.
What the acquisitions were worth. GoodwillImpairmentLoss is 0 in every year 2019–2025 (XBRL, annual and the Q2 interim tests). Goodwill went $5,032.1m (2020) → $10,575.4m (2025) → $17,554.7m (2026-06-30) with no write-down. Against that, ROIC on an ever-larger acquired base rose rather than fell — the roll-up has so far earned its goodwill. The cushion is gone, though: goodwill now exceeds equity (S2, 2026-09-21).
Buybacks at what price. Quarterly purchases from the releases, Q2 2024 → Q2 2026: 18.4m shares for $1,585.9m, ~$86 a share pre-split, ~$43 post-split; FY2025 alone 7.4m shares for $665.2m, ~$90 pre-split (~$45 post-split); Q1 and Q2 2026 at "approximately $140" and "$141" (calls 2026-04-29 [2] and 2026-07-29 [2], Craig Lampo), ~$70 post-split — every tranche below today's $82.19. Small money: buybacks ran $585–731m a year, 12% of FY2025 OCF. The pay link S3's proxy skim found (bonus on revenue and Adjusted Diluted EPS growth, capped at 17.5% / 27.5%) sits beside buybacks too small to move EPS by more than ~1% a year — not a flag at this scale.
Verdict — compounds. ~32% incremental ROIC over five years, no impairments, a share count held flat, and repurchases made below today's price. Caveats carried: two-thirds of cash went to M&A and the $10.5bn CommScope return is unproven; the verdict should be re-read at the FY2027 10-K.
Earnings quality
Sources: the non-GAAP reconciliation tables (headed "RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES", operating results) in the releases of 2025-01-22 (FY2024 and FY2023 columns), 2026-01-28 (FY2025, FY2024), 2026-04-29 (Q1 2026) and 2026-07-29 (Q2 and H1 2026); XBRL for the cash-flow and balance-sheet series.
1. The non-GAAP bridge (net income attributable, $m, and diluted EPS).
| Period | GAAP EPS | Acquisition-related | Excess tax benefit (SBC) — removed | Discrete tax items | Other | Adjusted EPS |
|---|---|---|---|---|---|---|
| FY2023 | $1.55 | +30.2 (+$0.02) | −82.4 (−$0.07) | — | bargain-purchase gain −5.4 | $1.51 |
| FY2024 | $1.92 | +105.3 (+$0.08) | −142.6 (−$0.11) | −18.6 (−$0.01) | — | $1.89 |
| FY2025 | $3.34 | +89.2 (+$0.07) | −246.6 (−$0.19) | +100.0 (+$0.08) | — | $3.34 |
| Q1 2026 | $0.72 | +99.5 (+$0.08) | −50.9 (−$0.04) | +290.0 (+$0.22) | — | $1.06 |
| Q2 2026 | $1.37 | +18.0 (+$0.01) | −80.5 (−$0.06) | +39.0 (+$0.03) | — | $1.35 |
Read it from the bottom of the table up. Through FY2025 adjusted EPS was at or below GAAP in every year, because Amphenol strips the excess tax benefit on option exercises out of its adjusted number — an unusually conservative definition. Acquisition-related expenses are added back in three years of three (a serial acquirer's recurring cost, $34.6m → $127.4m → $103.4m at the operating line, 0.3–0.8% of sales) — a flag by the rule, mitigated by the offset. The change is in the last three quarters: discrete tax items added back three quarters running, $429m in total ($100m China accrual Q4 2025; $130m more China plus $160m reassessment of prior years not under the China inquiry, Q1 2026; $39m "various foreign tax matters", Q2 2026 — release notes (iii)). In H1 2026 adjusted EPS ran $0.32 above GAAP ($2.42 vs $2.10, 2026-07-29 reconciliation), $0.26 of it discrete tax. A one-off in three consecutive periods, whose first estimate was exceeded 4.3x, is flag 2. Management's own read is that the charges moved the run-rate tax rate — it raised the adjusted ETR to 27.0% (from 24.5% a year earlier) — which is the right direction; the excluded prior-year catch-up is what to watch.
2. Stock-based compensation. FY2023 $99.0m = 0.8% of revenue, 4.6% of FCF ($2,159.9m); FY2024 $109.5m = 0.7% / 5.1% of $2,157.1m; FY2025 $135.4m = 0.6% / 3.1% of $4,392.9m; H1 2026 $79.6m = 0.5% / 3.9% of $2,036.7m (FCF as the releases define it, OCF less capex net of disposals). FCF after SBC is ~96% of FCF. Clean. (Option-driven dilution is the real cost and is covered under S2.)
3. Cash conversion. OCF / net income (incl. NCI, XBRL ProfitLoss): FY2023 1.30 (2,528.7 / 1,945.5), FY2024 1.15 (2,814.7 / 2,441.6), FY2025 1.25 (5,374.7 / 4,305.3), H1 2026 0.98 (2,678.7 / 2,727.5). Accruals, (NI − OCF) / average total assets: FY2023 −3.7%, FY2024 −2.0%, FY2025 −3.7%, H1 2026 +0.1% (half-year). Negative accruals three years running — clean. H1 2026 is the one to watch: a $1,176.4m working-capital build (vs $374.3m in H1 2025) with a $279.9m non-cash deferred-tax provision propping OCF (10-Q cash-flow statement). The CFO called inventory, DSO and payable days "within our normal trend ranges" (call 2026-07-29 [2]); the figures below agree.
4. Working capital. Quarter-end balance over quarter revenue (DSO) or cost of sales (DIO), from XBRL:
| Quarter end | DSO (days) | DIO (days) |
|---|---|---|
| 2023-12-31 | 72.4 | 89.5 |
| 2024-12-31 | 70.1 | 82.5 |
| 2025-06-30 | 68.8 | 79.4 |
| 2025-12-31 | 67.4 | 79.2 |
| 2026-06-30 | 70.6 | 79.5 |
DSO flat in a 67–72 band, DIO down from ~90 to ~79 while revenue grew 2.6x. The Q2 2026 DSO uptick includes CommScope's acquired receivables. Clean.
5. Costs moved onto the balance sheet. No capitalised-software tag in Amphenol's XBRL; the costs that are capitalised are capex, which grew faster than revenue in FY2024 (+78% vs +21%) and in line in FY2025 (+50% vs +52%), and which the CFO guides to the top of or slightly above 3–4% of sales for H2
- Customer co-investment in capacity is mentioned (call 2026-04-29 [12]) but never quantified —
where it lands on the balance sheet is not disclosed. No flag; one open question.
EQ result: 2 flags — discrete tax charges added back three quarters running ($429m, Q4 2025 – Q2 2026), and acquisition costs added back in 3 of 3 years (small, and more than offset through FY2025 by the excess-tax-benefit removal). Everything cash-side is clean.
Transcripts — FY2026-Q1 (2026-04-29) and FY2026-Q2 (2026-07-29), §3.1 order
dossier-2026-09-21.md read only the prepared remarks and the first five analyst exchanges of the Q2 2026 call (from Equibles). This pass read both calls in full from the market data archive, plus the outlook passage of each of the six earlier calls for S8. The Q&A of FY2024-Q3 → FY2025-Q4 was not read; the dodge log starts at Q1 2026.
Guidance changes
- Q1 2026 (CFO, [2]): adjusted ETR raised to 27% "for the remainder of 2026"; China tax accrual +$130m and a $160m prior-year reassessment, both excluded from adjusted EPS; net interest ~$200m a quarter reiterated. CEO ([3]): Q2 guide $8.1–8.2bn / $1.14–1.16. CEO ([18]): CommScope $4.1bn / $0.15 reaffirmed, "roughly a $3.5 billion, maybe $3.6 billion business with sort of mid-teens growth expectations" at signing.
- Q2 2026 (CFO, [2]): 1.5m shares repurchased at $141; net leverage 1.3x; $80m net IEEPA tariff recovery inside the quarter. CEO ([3]): Q3 guide $9.3–9.4bn / $1.40–1.42, no further tariff recoveries assumed; CommScope raised to $4.6bn / $0.30. CFO ([28]): capex at the high end of 3–4% of sales, "maybe modestly higher" in H2.
What analysts asked about (by topic)
- Optics / CPO / copper-vs-fibre and what it does to content and margin — Q1: Delaney (CPO economics), Stein (active vs passive, pluggables to CPO), Wamsi Mohan (share in optical scale-up), Giordano (ASP vs pounds of copper); Q2: Daryanani (fibre inside the AI run rate), Stein (cabled backplane to PCB), Hardwick (CommScope in scale-up). The most-asked topic in both calls.
- CommScope — Q1: Samik Chatterjee (vs the signing plan, fibre supply); Q2: Volkmann (what drove the raise), Cardoso (why EPS accretion doubled on a 12% sales raise), Merchant and Buscaglia (fibre supply). Answer on margin: "over 20%" operating margin in Q2 including amortisation (Q2 [10]).
- Capacity, funding and customer commitments — Q1: Daryanani (multi-year capacity agreements), Merchant (pricing, lead times); Q2: Wamsi Mohan (capex level).
- Everything else — defence restocking (Q1 Junk), industrial sub-segments (Graham, both calls), buildings (Q1 Fox), power interconnect (Q2 Junk), model mix / geography (Q2 Giordano), hinges (Q2 Delaney), power electronics M&A (Q2 Spak), customer dual-sourcing (Q1 Spak), 2027 (Q1 Buscaglia).
The questions themselves say what the room is worried about: whether optics displaces the copper content Amphenol is paid for, and whether CommScope's fibre supply holds. Management's answer to the first is the same every time — "more of everything" — and it has not put a number on it.
Dodges
- Q1 2026 · CPO revenue/profit implications · Mark Delaney — asked what CPO means for Amphenol's revenue and profit potential versus current designs; the answer described breadth and customer aims, then: "And what does that mean in terms of the quantum of the business? I mean, that all, I think, remains to be seen" ([5]→[6], R. Norwitt).
- Q1 2026 · 2027 outlook · Andrew Buscaglia — "Look, in terms of 2027, I'm not going to try to give a prognosis for 2027" ([8]→[9], R. Norwitt). Policy (quarter-only guidance); a note.
- Q1 2026 · multi-year capacity agreements · Amit Daryanani — asked whether Amphenol/CommScope are being approached for them and how it would fund capacity; the answer confirmed customers participate in investments and widen order commitments, then: "I mean you're probably not going to hear us talk about it very explicitly" ([11]→[12], R. Norwitt). No amount, customer or term.
- Q1 2026 · content value vs copper volume · Joseph Giordano — "But I'm not going to be able to give you a pound and length kind of metric here." ([39]→[40], R. Norwitt).
- Q2 2026 · fibre share of the AI business · Amit Daryanani — asked for any framework on how big fibre is within the AI run rate; the answer listed copper, optics and power as "really significant pieces" "without putting, you know, to the decimal point numbers behind it" ([12]→[13], Richard Adam Norwitt). (The "$10.5 billion to $11 billion AI revenue run rate" in the question is the analyst's figure, not management's.)
Thread (two quarters): 1, 4 and 5 are one topic — the size and economics of the AI mix by technology. Nothing in a filing settles it today; the settling documents would be a technology or customer disaggregation in the FY2026 10-K revenue note, or the re-appearance of a ≥10% customer (already a kill criterion). Carried to the scorecard as a ⚠️ line and an S9 trigger.
Full notes, 21 Sep 2026 14 min read
APH — dossier, 2026-09-21
Slot names-ai-capex-3. Model-drafted unattended by the cloud research routine; nothing here is human-verified. Sources and locators are in relationships.yaml; figures below carry theirs inline. Anything from background knowledge is marked [background].
Price reference: $80.86 close, 2026-09-21 (market data get_latest_stock_price NYSE:APH; volume 6,609,560 shares, so roughly $534m traded that day — liquidity is not a constraint at any size this workspace would contemplate).
Read the share count before anything else. Amphenol effected a two-for-one stock split on 2026-09-02 (8-K filed 2026-09-04, Item 8.01: "The two-for-one stock split referenced above has now been effected."). Every per-share figure in every filing and transcript quoted below predates it and is therefore pre-split. Diluted weighted-average shares were 1,289.2m for Q2 2026; post-split that is ~2,578.4m, giving a market capitalisation of ~$208.5bn at $80.86, not the ~$104bn a naive read of the last 10-Q would produce. The Q3 guide of $1.40–$1.42 adjusted diluted EPS is $0.70–$0.71 post-split. This is the single easiest way to get this name wrong by a factor of two and it is why the split is recorded as an edge.
S1 — Source
watchlist (owner, Apple Stocks, 2026-09-20), cluster ai_semis, coverage sec_domestic, cik 820313. No Tier 0 promotion; queue.json has never promoted APH.
S2 — Kill test
All figures from the XBRL company facts of the SEC filings (data.sec.gov/api/xbrl/companyfacts, CIK 0000820313). Calendar fiscal year.
| FY | Revenue $m | Gross profit $m | GM % | Op income $m | Op margin % | Net income $m | OCF $m | Capex $m | FCF $m | Diluted WA shares m (as filed) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 10,876 | 3,402 | 31.3 | 2,105 | 19.4 | 1,591 | 1,540 | 360 | 1,180 | 626 |
| 2022 | 12,623 | 4,028 | 31.9 | 2,586 | 20.5 | 1,902 | 2,175 | 384 | 1,791 | 1,242 |
| 2023 | 12,555 | 4,084 | 32.5 | 2,560 | 20.4 | 1,928 | 2,529 | 373 | 2,156 | 1,241 |
| 2024 | 15,223 | 5,140 | 33.8 | 3,157 | 20.7 | 2,424 | 2,815 | 665 | 2,150 | 1,264 |
| 2025 | 23,095 | 8,518 | 36.9 | 5,869 | 25.4 | 4,270 | 5,375 | 997 | 4,378 | 1,278 |
Quarterly, the six most recent (10-Q / 10-K XBRL):
| Quarter ended | Revenue $m | Gross profit $m | GM % | Op income $m | Net income $m |
|---|---|---|---|---|---|
| 2025-03-31 | 4,811 | 1,644 | 34.2 | 1,025 | 738 |
| 2025-06-30 | 5,650 | 2,053 | 36.3 | 1,419 | 1,091 |
| 2025-09-30 | 6,194 | 2,359 | 38.1 | 1,702 | 1,246 |
| 2025-12-31 (derived) | 6,439 | 2,461 | 38.2 | 1,723 | 1,196 |
| 2026-03-31 | 7,620 | 2,800 | 36.7 | 1,832 | 933 |
| 2026-06-30 | 8,758 | 3,548 | 40.5 | 2,585 | 1,769 |
LTM (2025-07-01 → 2026-06-30): revenue $29,011.6m, gross profit $11,168.6m (38.5%), operating income $7,841.4m (27.0%), net income $5,143.4m, D&A $1,303.9m → EBITDA ~$9,145m.
Balance sheet at 2026-06-30 (10-Q): long-term debt and lease obligations $17,177.0m plus current portion $1,634.3m = $18,811.3m gross; cash $4,729.4m plus short-term investments $689.7m → net debt $13,392.2m, or 1.46x LTM EBITDA. Stockholders' equity $15,491.6m. Goodwill $17,554.7m — goodwill alone exceeds book equity, which is the arithmetic behind the company's own impairment risk factor.
Maturity wall (FY2025 10-K schedule, so pre-CommScope-drawdown): $937.2m due within twelve months, $1,950.9m in year two, $7,780.9m after year five. Liquidity is backstopped by a revolving credit facility, a US and a Euro commercial paper programme (nothing drawn at 2025-12-31 or 2024-12-31), and two delayed-draw term loans of which $1,534.1m each was drawn in January 2026 to fund CommScope.
Share count over five years — the thing that looks alarming and is not. 626m (2021) → 1,242m (2022) → 1,278m (2025) as filed, then a further doubling on 2026-09-02. Both jumps are two-for-one splits, not issuance. On a constant post-2026 basis the diluted count went from ~2,504m (2021) to ~2,555m (2025): ~2% over four years, against $3.2bn of buybacks and $2.7bn of dividends in that window. Amphenol does not fund itself with its own stock.
Analyst coverage count: not obtained this run (no source on this ladder gives a clean count). Six sell-side firms asked questions on the Q2 2026 call — Jefferies, J.P. Morgan, Evercore, Baird, Truist and TD Cowen appear in the turns read — which is a floor, not a count.
Verdict — survives, comfortably. A 27% operating margin, $4.4bn of FY25 free cash flow, net debt at 1.5x EBITDA and no dilution. The kill test does not fail; the risk here is the multiple and the durability of the demand, not solvency. The one caution the numbers themselves raise: FY25's margin expansion (20.7% → 25.4% operating) and Q2 2026's 40.5% gross margin are cycle-peak readings on a business that ran at ~32% gross margin for a decade, and $17.6bn of goodwill now sits against $15.5bn of equity.
S3 — Filings, gate-minimum
Read this run: the FY2025 10-K (Item 1A risk factors, Item 7 MD&A, Note 15 subsequent events), the Q2 2026 10-Q (MD&A delta, debt notes, acquisition note), the 2026 DEF 14A (ownership tables and the incentive-plan criteria), the Q2 2026 earnings call (turns 3–20 of 48, prepared remarks plus the first five analyst exchanges), and the complete SEC comment-letter exchange on the FY2024 10-K. Not read: the FY2024 10-K, older 10-Qs, the Q1 2026 call, the investor-day material.
The three biggest risks management itself discloses
- Non-US exposure and trade policy — Item 1A, "Risks Related to our Global Operations", first risk factor: "During 2025, non-U.S. markets constituted approximately 65% of the Company's net sales, with China constituting approximately 16% of the Company's net sales. The Company employs approximately 90% of its workforce outside the United States." The same paragraph adds that "approximately 79% of the Company's long-lived assets were located outside of the United States". Q2 2026's margin was flattered by net tariff refunds — management said excluding them operating margin "still reached nearly 29%" against the reported 29.8%, and guided that further net tariff recoveries would be immaterial.
- End-market cyclicality — Item 1A, "Risks Related to our End Markets": "The Company is dependent on end market dynamics to sell its products, and some of the Company's end markets are subject to cyclical and at times rapid periods of reduced demand." With IT datacom at 43% of Q2 2026 sales and the company attributing virtually all of that growth to AI, this generic risk factor is now concentrated in one place. It is already visible elsewhere in the mix: communications networks sales fell 6% organically year on year and are guided down in the mid-teens sequentially for Q3.
- Acquisition integration and goodwill — Item 1A: "The Company has completed numerous acquisitions in recent years, including five in 2025 and two in 2024, some of which are large and complex. Additionally, on January 9, 2026, the Company closed the CommScope acquisition, which is the largest acquisition in the Company's history." And, separately: "On December 31, 2025, the total assets of the Company were $36.2 billion, which included $10.6 billion of goodwill ... and $2.2 billion of other intangible assets, net." Post-CommScope that goodwill is $17.6bn.
Latest quarter, MD&A delta
Q2 2026 revenue $8,758.1m, +55% in USD, +54% constant currency, +30% organic. Segment mix moved hard: Communications Solutions is now ~62% of sales (from ~52% for FY25), Harsh Environment ~21%, Interconnect and Sensor Systems ~17%. Management's own end-market split for the quarter, from the call: IT datacom 43%, industrial 20%, communications networks 11%, automotive 10%, defence 8%, commercial air 4%, mobile devices 4%.
On the call the CEO reported record orders of $10.7bn, a 1.23 book-to-bill, orders +94% year on year and +63% organically, and raised the CommScope contribution to $4.6bn of 2026 sales and $0.30 of accretion from $4.1bn and $0.15. Q3 2026 guidance: sales $9.3–9.4bn, adjusted diluted EPS $1.40–$1.42 (pre-split; $0.70–$0.71 post-split), i.e. 50–52% sales growth.
Proxy skim
All executive officers and directors as a group (16 persons) hold 17,469,159 shares, 1.42% of the class as of 2026-03-23; every individual director and officer is marked "less than one percent". Five-percent holders: Vanguard 10.2%, BlackRock 8.0%, FMR 7.0%.
The incentive plan is the interesting part. For the CEO and CFO the 2025 quantitative criteria were revenue growth of 7% and Adjusted Diluted EPS growth of 11% for a 100% multiplier, and "To achieve a 200% quantitative portion of the incentive plan multiplier in 2025 would have required Company revenue growth of at least 17.5% and Company Adjusted Diluted EPS growth of at least 27.5%." Delivered: 52% and 77%. Two things follow. The plan is capped far below what this cycle pays, so there is no marginal bonus incentive to chase the AI number — a mild positive. And plan revenue growth is not adjusted for acquisitions, in a company that completed five acquisitions in 2025 and a $10.5bn one in 2026 — which is where this joins the comment letter below.
Insider pattern
3spread (insiders APH --days 365): 91 Form 4 filings in the twelve months to 2026-09-21, clustered on 2026-05-27 (an annual grant/vest date) and in the first week of August 2026, i.e. the window immediately after the 2026-07-29 results. sales APH: 10 Form 144 proposed sales since 2026-03-25, all in the same two windows (three around 2026-05-01–05, seven from 2026-07-31 to 2026-08-05). Direction is one-way — there are proposed sales and no purchases on file — but the clustering is exactly what a 10b5-1 / post-earnings-window programme looks like, and the individual Form 4 amounts were not itemised this run. Recorded as a pattern to watch, not as a signal.
Red-flag sweep — one real finding, and it closed
The SEC's Division of Corporation Finance, Office of Manufacturing, reviewed the FY2024 Form 10-K and issued comments on 2025-02-07. Comments 3 and 4 asked about Amphenol's ASC 805 acquisition disclosure. Amphenol responded on 2025-05-16 and supplementally on 2025-06-20 over the CFO's signature, arguing that because the interconnect market "is highly fragmented and comprised mostly of small, niche manufacturers" it discloses acquisition details "even when those acquisitions are immaterial or in many cases trivial in size", and concluding that "we continue to believe that the 2024 Acquisitions and the 2025 Acquisitions were not material, individually or in the aggregate, to the Company". The staff closed the review on 2025-06-25: "We have completed our review of your filing."
No restatement, no amendment, no NT 10-K. The finding is not a defect — it is that the SEC pressed this exact question seven months before Amphenol closed the largest acquisition in its history, one that added $7.0bn of goodwill in a single quarter. The company's answer was "individually and in aggregate immaterial". That answer was about 2024 and 2025 and it does not carry to CommScope, which is separately disclosed — but the roll-up is now large enough that "immaterial in aggregate" is a claim worth re-testing at the next 10-K. The efts.sec.gov full-text sweep for "changes in accountants" / "restatement" was not run this session (time), so auditor change is unchecked beyond the absence of an NT 10-K or 8-K Item 4.01 in the filing index.
Equibles GetCustomerConcentration (3 most recent disclosing filings): the last figure Amphenol tagged is an 11%-of-revenue largest customer for FY2020, in the 10-K filed 2023-02-08. Nothing since. At 43% of sales in one end market, the absence of a disclosure is the disclosure.
S5 — Ownership
Top managers, 13F report date 2026-06-30 (threespread.py holders APH, CUSIP 032095101; 1,614 filers reporting 601,165,439 shares — pre-split basis):
| Manager | Shares | $m | QoQ | Status |
|---|---|---|---|---|
| BlackRock | 101,252,038 | 17,852.8 | −714,028 | trimmed |
| State Street | 59,492,948 | 10,504.1 | +2,096,530 | added |
| T. Rowe Price | 32,011,336 | 5,644.2 | +5,824,431 | added |
| Wellington | 16,579,919 | 2,923.4 | +1,578,248 | added |
| Bank of America | 16,201,231 | 2,856.6 | −4,474,455 | trimmed |
| MFS | 10,522,112 | 1,932.5 | −3,442,515 | trimmed |
| Jupiter Topco LLC | 9,077,181 | 1,600.5 | +9,077,181 | NEW |
| Sixth Street Partners | 7,441,815 | 1,312.1 | +7,441,815 | NEW |
| Wells Fargo | 7,056,130 | 1,244.1 | −7,152,122 | trimmed |
⚠️ The quarter is incompletely ingested — 1,614 filers against 2,099 for 2026-03-31. The script names ten prior holders with no 13F in the quarter yet, including FMR (79.5m shares), JPMorgan (49.3m), Capital International (35.3m), Geode (31.3m), Janus Henderson (18.9m), Morgan Stanley (17.5m) and Northern Trust (13.5m). No exit may be read from any of those absences.
Two of those absences have a documented cause. Both "VANGUARD CAPITAL MANAGEMENT LLC" (159.8m shares) and "VANGUARD PORTFOLIO MANAGEMENT LLC" (35.9m) are listed as prior holders with nothing in the current quarter. The proxy explains why: "On March 26, 2026, The Vanguard Group filed an amendment to its Schedule 13G disclosing that, as a result of an internal realignment, it is no longer deemed to beneficially own any shares of Common Stock." Vanguard restructured which legal entities report. This is almost certainly the same cause behind the "both Vanguard entities absent" warning carried in the MRVL scorecard from slot names-ai-capex-2 — it is a reporting change across Vanguard, not a position change in any one issuer.
13D/G: nine filings on file, all 13G or 13G/A — passive. No 13D, no activist.
Insider ownership: 1.42% for the 16 officers and directors as a group.
Short interest (Equibles GetShortInterest, FINRA settlements): 63.95m (2026-06-30) → 66.03m → 61.67m → 59.09m (2026-08-14) → 27.12m (2026-08-31). The last step is a 54% fall in one settlement, alongside average daily volume halving from 22.5m to 11.5m. That boundary sits days before the 2026-09-02 two-for-one split, and the volume series halves with it, so the drop reads as a split-restatement artefact in the feed rather than a covering event. Do not read a squeeze into it. On either basis days-to-cover is 1.6–2.6 — there is no crowded short here. The tool's model estimate for the 2026-09-15 settlement (~28.3m) is explicitly a prediction, not FINRA data.
Shelf, ATM and buyback. A live automatic shelf: S-3ASR filed 2026-03-02 — Amphenol is a well-known seasoned issuer and can sell securities at will; it has funded every recent acquisition with debt and cash rather than stock, but the capacity is there and unlimited by construction. Buyback: $2.0bn authorised 2024-04-23, $411.1m remaining as of 2026-07-29, i.e. nearly exhausted and due for re-authorisation. Repurchases have run $585m–$935m a year for a decade — $665.2m in FY25 and $386.0m in H1 2026 — so this is a steady offset-the-grants programme, not a capital-return lever. Dividends were $802.2m in FY25 and $614.0m in H1 2026. No ATM programme was sought (the company is investment grade and does not run one) — not checked, and absence is not proof.
Who is on the other side: index funds and long-only growth managers, with T. Rowe the loudest active buyer of the quarter and two new positions above $1.3bn. No activist, no crowded short, no shelf overhang that has ever been used for equity. The other side of this trade is the multiple.
S8 — Valuation and sizing (proposed only; owner-only items OPEN)
At $80.86 (2026-09-21) with ~2,578.4m post-split diluted shares: market cap ~$208.5bn, net debt $13.4bn, EV ~$221.9bn.
Against LTM: 7.6x EV/sales, 24.3x EV/EBITDA, 40.5x trailing GAAP EPS (LTM GAAP diluted EPS $1.995 post-split).
Out-year model. Revenue is built from H1 2026 actual plus the Q3 guide midpoint plus a Q4 in line with the sequential trend; margins from the Q2 2026 run rate, which management calls a record.
| FY2026E | FY2027E | FY2028E | |
|---|---|---|---|
| Revenue $m | 35,530 | 43,350 | 51,150 |
| Growth | +54% | +22% | +18% |
| Net margin | 19.5% | 20.0% | 20.5% |
| Net income $m | 6,928 | 8,670 | 10,485 |
| Diluted shares m (post-split) | 2,578 | 2,580 | 2,580 |
| EPS | $2.69 | $3.36 | $4.07 |
| Implied P/E at $80.86 | 30.1x | 24.1x | 19.9x |
| Case | FY2028 EPS | Multiple | Value |
|---|---|---|---|
| Bear — AI datacom orders roll over in 2027, revenue settles at $38bn, net margin back to 16% | $2.36 | 18x | ~$42 |
| Base — the table above | $4.07 | 24x | ~$98 |
| Bull — AI content per rack keeps compounding, 22% growth holds, margin 21.5% | $4.90 | 30x | ~$147 |
The base case is +21% over three years from today's price, which is not much for the risk in the bear column. What the model is really saying: at 30x FY26 the market already pays for the AI mix, and the return from here depends on 2028 revenue being roughly $51bn — more than double FY2025.
⏳ Buy price and position size are owner-only and stay OPEN (user). For the record the liquidity constraint is not binding: ~$534m traded on 2026-09-21.
S9 — Monitoring
Next earnings: Q3 2026 results, expected in the last week of October 2026 — derived from filing cadence (Q3 2025 10-Q filed 2025-10-24; Q2 2026 call 2026-07-29, 10-Q 2026-07-31), not from a calendar feed. market data's earnings calendar needs a paid plan on this account, the same limit slot names-ai-capex-1 hit.
Filing feed: the Tier 0 EDGAR sweep covers cik 820313 (ledger/research/tools/watch_edgar.py), so 8-K, 10-Q, S-3, Form 4 and any Item 4.01 arrive without a subscription.
The leading indicator: orders and book-to-bill. Amphenol reports both every quarter on the call and they lead revenue by roughly two quarters. Q2 2026 was a record $10.7bn of orders at 1.23 book-to-bill, +63% organically. A book-to-bill that falls below 1.0 — before any revenue miss — is the earliest disclosed number that would tell you the AI interconnect build has turned. Secondary: the organic IT datacom growth rate (+63% in Q2) and the communications networks line, which is already contracting organically and is guided down mid-teens sequentially in Q3.
Trigger that converts this to a buy: a quarter in which book-to-bill stays above 1.0 and organic IT datacom growth stays positive while the stock de-rates below ~20x the forward EPS on this model — i.e. the cycle is intact and the multiple has broken. On the FY2027E line that is roughly $67. The specific price and the size remain the owner's.